SCM
ANGO icon

Stonepine Capital Management’s AngioDynamics ANGO Stock Holding History

Stonepine Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,000
Closed -$670K – 69
2025
Q3 		$670K Sell
60,000
-17,141
-22% -$165K 0.54% 35
2025
Q2 		$765K Buy
+77,141
New +$755K 0.75% 33

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KK
Kotler Kevin $427M AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Stonepine Capital Management's ANGO Position: Q4 2025 in Review

Stonepine Capital Management sold out of AngioDynamics (ANGO) in Q4 2025, closing a stake of 60,000 shares — an estimated $670K sold.

Stonepine Capital Management first reported a position in ANGO in Q2 2025 and held it in 2 quarters. The position peaked at $765K in Q2 2025. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

  • Stonepine Capital Management reported no remaining AngioDynamics position as of Q4 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 60,000 AngioDynamics shares in Q4 2025, an estimated $670K.
  • Stonepine Capital Management first reported a position in AngioDynamics in Q2 2025 and held it in 2 quarters.
  • Stonepine Capital Management's AngioDynamics position peaked at $765K in Q2 2025.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on Stonepine Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.